- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 5/073 - Embryonic cells or tissues; Foetal cells or tissues
Patent holdings for IPC class C12N 5/073
Total number of patents in this class: 1382
10-year publication summary
|
84
|
110
|
116
|
105
|
120
|
130
|
131
|
118
|
109
|
28
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celularity, Inc. | 208 |
46 |
| ViaCyte, Inc. | 183 |
26 |
| Osiris Therapeutics, Inc. | 95 |
25 |
| Accelerated Biosciences Corp. | 38 |
20 |
| Depuy Synthes Products, LLC | 2880 |
16 |
| Pluri Biotech Ltd. | 42 |
16 |
| Anthrogenesis Corporation | 76 |
15 |
| The Regents of the University of California | 18943 |
14 |
| Kyoto University | 2732 |
13 |
| CellResearch Corporation Pte Ltd. | 54 |
13 |
| Pluristem Ltd. | 41 |
12 |
| Astellas Institute for Regenerative Medicine | 118 |
10 |
| Children's Hospital Medical Center | 690 |
9 |
| Inguran, LLC | 222 |
9 |
| Stemnion, Inc. | 62 |
9 |
| University Health Network | 979 |
9 |
| Centre National de La Recherche Scientifique | 9632 |
8 |
| President and Fellows of Harvard College | 5792 |
8 |
| Kaneka Corporation | 4445 |
8 |
| Ethicon, Inc. | 1310 |
8 |
| Other owners | 1088 |